Cathepsin E has been suggested as a possible marker for pancreatic tumors (50,51), and interestingly, a recent study demonstrated a positive correlation between enhanced serum levels of cathepsin E and poor clinical prognosis in breast cancer patients. This evidence concerns the gene CTSE and breast cancer.